Equities

Halberd Corp

HALB:PKC

Halberd Corp

Actions
  • Price (USD)0.008
  • Today's Change-0.001 / -5.88%
  • Shares traded563.34k
  • 1 Year change-2.44%
  • Beta-3.9246
Data delayed at least 15 minutes, as of Jun 14 2024 20:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.

  • Revenue in USD (TTM)281.24k
  • Net income in USD25.34k
  • Incorporated2020
  • Employees3.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eiger Biopharmaceuticals Inc15.77m-74.96m4.89m25.00------0.3098-50.80-50.8010.69-9.770.19850.00649.19630,920.00-94.31-60.25-186.10-76.5199.91---475.26-823.590.6809-22.031.54--16.98--22.54--10.51--
Emmaus Life Sciences Inc28.46m-4.74m4.90m55.00------0.1723-0.0931-0.09310.3905-0.67730.63490.81849.36517,454.50-10.58------93.69---16.66--0.12490.1426-----10.77--33.37------
Portage Biotech Inc0.00-144.90m4.95m7.00--0.1545-----7.96-7.960.001.620.00----0.00-111.60-19.70-113.27-26.48------------0.0087-------520.10------
Applied DNA Sciences Inc5.52m-12.50m4.96m53.00------0.8992-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
Processa Pharmaceuticals Inc0.00-9.83m5.00m13.00--0.5626-----6.29-6.290.003.110.00----0.00-87.82-84.35-102.32-90.03------------0.0012------59.45---34.05--
MyMD Pharmaceuticals Inc0.00-7.07m5.05m9.00--0.2234-----5.53-5.530.0010.280.00----0.00-25.59-76.20-31.13-84.38--7.64---4,290.96----0.00------49.15------
Halberd Corp281.24k25.34k5.09m3.003.45--200.5118.090.00230.00230.0018-0.00020.14490.03032.52--1.31--4.58--50.00--9.01--0.26611.351.02--271.52---60.11------
Galera Therapeutics Inc0.00-45.75m5.11m7.00---------0.9971-0.99710.00-2.480.00----0.00-115.30-83.69-142.79-97.54-----------6.499.23------5.05---29.84--
Pineapple Inc157.59k376.69k5.12m--0.6283--13.4332.470.11140.11140.0028-0.03180.0388------9.28--53.43---412.55--239.03--0.00-----------611.10------
Sonnet Biotherapeutics Holdings Inc92.74k-8.43m5.14m12.00--1.68--55.37-5.28-5.280.03150.98130.0097--0.22487,728.33-87.68---194.11-------9,086.22-----138.210.00---57.76--36.64------
HST Global Inc0.00-141.11k5.14m1.00---------0.0269-0.02690.00-0.11930.00-------29,397.92-5,836.01---------------24.24---------0.7858------
Lipella Pharmaceuticals Inc477.45k-4.74m5.17m5.00--1.87--10.83-0.7633-0.76330.07470.36380.1232--6.2595,490.00-122.37---146.33-------993.39------0.00--144.15---77.81------
Helix BioMedix, Inc.2.07m-2.58m5.23m8.00--3.35--2.53-15.60-15.6012.486.950.80471.874.55258,238.80-100.64-146.31-120.73-173.5768.9630.80-125.06-527.121.69-14.570.00--122.0792.8067.73---29.08--
Stemtech Corp4.64m-4.08m5.41m45.00------1.17-0.0624-0.06240.0619-0.00921.098.3565.16103,098.40-96.70------76.09---88.58--0.1045-1.812.27--------------
Data as of Jun 14 2024. Currency figures normalised to Halberd Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.